Company

Phenoquest AG is a biopharmaceutical company dedicating its research activities to the discovery and development of innovative treatments for psychiatric disorders. The key project focuses on developing antibody therapeutics for the treatment of depression.

The research unit comprises modern laboratories and a team of scientists with profound scientific expertise combined with multifarious experience in industrial and academic research in various therapeutic areas.

In addition to the in-house projects, Phenoquest offers the use of its behavioural pharmacology platform to validate gene targets and characterise drug candidates on a commercial service basis.

Phenoquest was founded in 2011 and is located in Martinsried, near Munich.